Artificial neural network method for predicting HIV protease cleavage sites in protein

Journal of Protein Chemistry

Volumn 17, Issue 7, 1998, Pages 607-615

  Cai, Yu Dong ^a   Yu, Hanry ^b   Chou, Kuo Chen ^c  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c Upjohn Laboratories ^*  (United States)

Author keywords

Artificial neural network; Cleavage sites; HIV protease; T. Kohonen's self organization model

Indexed keywords

OLIGOPEPTIDE; PROTEINASE; PROTEINASE INHIBITOR; VIRUS ENZYME;

ARTICLE; ARTIFICIAL NEURAL NETWORK; HUMAN IMMUNODEFICIENCY VIRUS 1; MODEL; NONHUMAN; PREDICTION; PROTEIN DEGRADATION; TRAINING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031762518     PISSN: 02778033     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02780962     Document Type: Article

References (28)

1. Ashorn, P., McQuade, T. J., Thaisrivongs, S., Tomasselli, A. G., Tarpley, W. J., and Moss, B. (1990). An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection, Proc. Natl. Acad. Sci. USA 87, 7472-7476.
2. Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., Rozenbaum, W., and Montagnier, L. (1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS), Science 220, 868-871.
3. Chou, J. J. (1993). Predicting cleavability of peptide sequences by HIV protease via correlation-angle approach, J. Protein Chem. 12, 291-302.
4. Chou, K. C. (1993). A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins, J. Biol. Chem. 268, 16938-16948.
5. Chou, K. -C. (1996). Prediction of human immunodeficiency virus protease cleavage sites in proteins, Anal. Biochem. 233, 1-14.
6. Chou, K. C., and Zhang, C. T. (1993). Studies on the specificity of HIV protease: An application of Markov chain theory, J. Protein Chem. 12, 709-724.
7. Chou, K. C., Zhang, C. T., and Kézdy, F. J. (1993). A vector projection approach to predicting HIV protease cleavage sites in proteins, Proteins Struct. Funct. Genet. 16, 195-204.
8. Chou, K. C., Tomasselli, A. G., Reardon, I. M., and Heinrikson, R. L. (1996). Predicting HIV protease cleavage sites in proteins by a discriminant function method, Proteins Struct. Funct. Genet. 24, 51-72.
9. Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., White, G., Foster, P., and Markham, P. D. (1984). Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS, Science 224, 500-503.
10. Graves, B. J., Hatada, M. H., Miller, J. K., Graves, M. C., Roy, S. Cook, C. M., Króhn, A., Martin, J. A., and Roberts, N. A. (1992). The three-dimensional x-ray crystal structure of HIV-1 protease complexed with a hydroxyethylene inhibitor, in Structure and Function of the Aspartic Protease: Genetics, Structure and Mechanisms (Dunn, B., ed.), Plenum Press, New York, pp. 455-460.
11. Hellen, C. U. T., Kräusslich, H. G., and Wimmer, E. (1989). Proteolytic processing of polyproteins in the replication of RNA viruses, Biochemistry 28, 9881-9890.
12. Henderson, L. E., Benveniste, R. E., Sowder, R. C., Copeland, T. D., Schutz, A. M., and Oroszlan, S. (1988). Molecular characterization of gag proteins from simian immunodeficiency virus (SI-VMne), J. Virol. 62, 2587-2595.
13. Kohl, N. E., Emini, E. A., Schlief, W. A., Davis, L. J., Heimbach, J., Dixon, R. A. F., Scolnik, E. M., and Sigal, I. S. (1988). Active human immunodeficiency virus protease is required for viral infectivity, Proc. Natl. Sci. USA 85, 4685-4690.
14. Kohonen, T. (1988). Introduction to neural computing, Neural Networks 1, 3-16.
15. Lapatto, R., Blundell, T., Hemmings, A., Overington, J., Wilderspin, A., Wood, S., Merson, J. R., White, P. J., Danley, D. E., Geoghegan, K. F., Hawrylik, S. J., Lee, S. W., Scheid, K. G., and Hobart, P. M. (1989). X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retrviral enzymes, Nature 342, 299-302.
16. McQuade, T. J., Tomasselli, A. G., Liu, L., Karacostas, V., Moss, B., Sawyer, T. K., Heinrikson, H. L., and Tarpley, W. J. (1990). An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection, Science 247, 454-456.
17. Meek, T. D., Lambert, D. M., Dreyer, G. B., Carr, J. T., Tomaszek, Jr., T. A., Moore, M. L., Strickler, J. E., Debouck, C., Hyland, L. J., Matthews, J. T., Metcalf, B. W., and Petteway, S. R. (1990). Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues, Nature 343, 90-92.
18. Miller, M., Schneider, J., Sathyanarayana, B. K., Toth, M. V., Marshall, L. M., Clawson, L., Selk, L., Kent, S. B. H., and Wlodawer, A. (1989). Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution, Science 246, 1149-1152.
19. Mitsuya, H., Yarchoan, R., and Broder, S. (1990). Molecular targets for AIDS therapy, Science 249, 1533-1544.
20. Pearl, L., and Talyor, W. (1987). A structural model for the retroviral proteases, Nature 329, 351-354.
21. Poorman, R. A., Tomasselli, A. G., Heinrikson, R. L., and Kézdy, F. J. (1991). A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base, J. Biol. Chem. 266, 14554-14561.
22. Putney, S. (1992). How antibodies block HIV infection: Paths to an AIDS vaccine, TIBS 17, 191-196.
23. Roberts, N. A., Martin, J. A., Kinchington, D., Broadhurst, A. V., Craig, J. C., Duncan, I. B., Galpin, S. A., Handa, B. K., Kay, J., Krohn, A., Lambert, R. W., Merrett, J. H., Mills, J. S., Parkes, K. E. B., Redshaw, S., Ritchie, A. J., Taylor, D. L., Thomas, G. J., and Machin, P. J. (1990), Rational design of peptide-based HIV proteinase inhibitors, Science 248, 358-361.
24. Seelmeier, S., Schmidt, H., Turk, V., and von der Helm, K. (1988). Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A, Proc. Natl. Acad. Sci. USA 85, 6612-6616.
25. Toh, H., Ono, M., Saigo, K., and Miyata, T. (1985). Retroviral gag and DNA endonuclease coding sequences in IgE-binding factor gene, Nature 315, 691-691.
26. Tomasselli, A. G., Hui, J. O., Sawyer, T. K., Thaisrivongs, S., Hester, J. B., and Heinrikson, R. L. (1991). The evaluation of non-viral substrates of the HIV protease as leads in the design of inhibitors for AIDS therapy, in Structure and Function of Aspartic Proteases (Dunn, B. M., ed.), Plenum Press, New York, pp. 469-482.
27. Wlodawer, A., and Erickson, J. W. (1993). Structure-based inhibitors of HIV-1 protease, Annu. Rev. Biochem. 62, 543-585.
28. Zhang, C. T., and Chou, K. C. (1994). An alternate-subsite-coupled model for predicting HIV protease sites in proteins, Protein Eng. 7, 65-73.